Provided by Tiger Trade Technology Pte. Ltd.

AbbVie

253.18
-2.3000-0.90%
Volume:112.20K
Turnover:28.48M
Market Cap:447.47B
PE:71.53
High:254.50
Open:254.17
Low:252.72
Close:255.48
52wk High:267.47
52wk Low:190.75
Shares:1.77B
Float Shares:1.76B
Volume Ratio:2.32
T/O Rate:0.01%
Dividend:6.83
Dividend Rate:2.70%
EPS(TTM):3.54
EPS(LYR):2.36
ROE:6225.00%
ROA:10.51%
PB:-75.39
PE(LYR):107.28

Loading ...

Canaccord Genuity Adjusts AbbVie Price Target to $290 From $282, Maintains Buy Rating

MT Newswires Live
·
Aug 03

AbbVie price target raised to $285 from $265 at Cantor Fitzgerald

TIPRANKS
·
Aug 03

Street View: Strength in AbbVie's Immunology Pipeline to Support Revenue Growth

Reuters
·
Aug 03

Krystal Biotech Q2 Revenue Rises on Vyjuvek Strength

Reuters
·
Aug 03

Integer Holdings Q2 Sales Fall 2.6%; KKR to Buy Company for $5.7 Billion

Reuters
·
Aug 03

Indivior Pharmaceuticals Beats Q2 Revenue on Sublocade Growth, Raises FY Guidance

Reuters
·
Aug 03

China's WuXi AppTec H1 Revenue Rises, Raises 2026 Guidance

Reuters
·
Aug 03

U.S. Research Roundup-Abbvie, Amazon, Illumina

Reuters
·
Aug 03

JPMorgan Adjusts Price Target on AbbVie to $285 From $280

MT Newswires Live
·
Aug 01

Abbvie Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 01

Analysts Offer Insights on Healthcare Companies: Viking Therapeutics (VKTX), AbbVie (ABBV) and Cencora (COR)

TIPRANKS
·
Aug 01

AbbVie Earnings Beat Forecasts as Skyrizi Sales Soar 24%. Why the Stock is Falling.

Dow Jones
·
Aug 01

Sector Update: Healthcare

MT Newswires Live
·
Aug 01

AbbVie Targets Ovarian Cancer Biomarkers With New FRa Concordance Study

TIPRANKS
·
Aug 01

AbbVie’s New AML Combo Trial Aims to Boost Its Oncology Pipeline

TIPRANKS
·
Aug 01

AbbVie Publishes Pipeline Presentation Highlighting July 2026 R&D Program Updates

Reuters
·
Jul 31

AbbVie Stock Falls as Guidance Cut Overshadows Strong Q2 Earnings Beat

Benzinga Earnings
·
Jul 31

Movement Alert|AbbVie Falls 3.04% in Regular Trading, Q2 Beat Overshadowed by Full-Year EPS Guidance Cut on Acquisition Dilution

Market Focus
·
Jul 31

AbbVie says ‘quite pleased’ with Skyrizi momentum

TIPRANKS
·
Jul 31

AbbVie Has 2Q Beat Helped by Skyrizi and Rinvoq

Dow Jones
·
Jul 31